Skip to main content

Guardant Health to Participate in Upcoming November Investor Conferences

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the following investor conferences:

  • Jefferies 14th Annual Global Healthcare Conference in London, UK

    Presentation on Thursday, November 16 at 9:00 a.m. Greenwich Mean Time
  • Piper Sandler 35th Annual Healthcare Conference in New York, NY

    Fireside Chat on Tuesday, November 28 at 9:30 a.m. Eastern Time

Interested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at:

About Guardant Health

Guardant Health is a leading precision oncology company focused on helping every person live a life free from cancer. Founded in 2012, Guardant is transforming cancer care by providing critical insights into what drives the disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve patient outcomes across all stages of cancer, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For more information, visit and follow the company on LinkedIn and X (Twitter).


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.